307 related articles for article (PubMed ID: 32748023)
1. Bone marrow mesenchymal stem cell-derived exosomes attenuate cardiac hypertrophy and fibrosis in pressure overload induced remodeling.
Chen F; Li X; Zhao J; Geng J; Xie J; Xu B
In Vitro Cell Dev Biol Anim; 2020 Aug; 56(7):567-576. PubMed ID: 32748023
[TBL] [Abstract][Full Text] [Related]
2. Exosomes from mesenchymal stem cells overexpressing MIF enhance myocardial repair.
Liu X; Li X; Zhu W; Zhang Y; Hong Y; Liang X; Fan B; Zhao H; He H; Zhang F
J Cell Physiol; 2020 Nov; 235(11):8010-8022. PubMed ID: 31960418
[TBL] [Abstract][Full Text] [Related]
3. Zerumbone prevents pressure overload-induced left ventricular systolic dysfunction by inhibiting cardiac hypertrophy and fibrosis.
Sari N; Katanasaka Y; Sugiyama Y; Sunagawa Y; Miyazaki Y; Funamoto M; Shimizu S; Shimizu K; Murakami A; Mori K; Wada H; Hasegawa K; Morimoto T
Phytomedicine; 2021 Nov; 92():153744. PubMed ID: 34563985
[TBL] [Abstract][Full Text] [Related]
4. Exosomes derived from SDF1-overexpressing mesenchymal stem cells inhibit ischemic myocardial cell apoptosis and promote cardiac endothelial microvascular regeneration in mice with myocardial infarction.
Gong XH; Liu H; Wang SJ; Liang SW; Wang GG
J Cell Physiol; 2019 Aug; 234(8):13878-13893. PubMed ID: 30720220
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-elicited mesenchymal stem cell-derived exosomes facilitates cardiac repair through miR-125b-mediated prevention of cell death in myocardial infarction.
Zhu LP; Tian T; Wang JY; He JN; Chen T; Pan M; Xu L; Zhang HX; Qiu XT; Li CC; Wang KK; Shen H; Zhang GG; Bai YP
Theranostics; 2018; 8(22):6163-6177. PubMed ID: 30613290
[TBL] [Abstract][Full Text] [Related]
6. Exosomes derived from umbilical cord mesenchymal stem cells alleviate viral myocarditis through activating AMPK/mTOR-mediated autophagy flux pathway.
Gu X; Li Y; Chen K; Wang X; Wang Z; Lian H; Lin Y; Rong X; Chu M; Lin J; Guo X
J Cell Mol Med; 2020 Jul; 24(13):7515-7530. PubMed ID: 32424968
[TBL] [Abstract][Full Text] [Related]
7. Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Promote Fibroblast-to-Myofibroblast Differentiation in Inflammatory Environments and Benefit Cardioprotective Effects.
Shi Y; Yang Y; Guo Q; Gao Q; Ding Y; Wang H; Xu W; Yu B; Wang M; Zhao Y; Zhu W
Stem Cells Dev; 2019 Jun; 28(12):799-811. PubMed ID: 30896296
[TBL] [Abstract][Full Text] [Related]
8. A critical role of cardiac fibroblast-derived exosomes in activating renin angiotensin system in cardiomyocytes.
Lyu L; Wang H; Li B; Qin Q; Qi L; Nagarkatti M; Nagarkatti P; Janicki JS; Wang XL; Cui T
J Mol Cell Cardiol; 2015 Dec; 89(Pt B):268-79. PubMed ID: 26497614
[TBL] [Abstract][Full Text] [Related]
9. C-C chemokine receptor 5 signaling contributes to cardiac remodeling and dysfunction under pressure overload.
Wang X; Li W; Yue Q; Du W; Li Y; Liu F; Yang L; Xu L; Zhao R; Hu J
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33200795
[TBL] [Abstract][Full Text] [Related]
10. Myocardial reparative functions of exosomes from mesenchymal stem cells are enhanced by hypoxia treatment of the cells via transferring microRNA-210 in an nSMase2-dependent way.
Zhu J; Lu K; Zhang N; Zhao Y; Ma Q; Shen J; Lin Y; Xiang P; Tang Y; Hu X; Chen J; Zhu W; Webster KA; Wang J; Yu H
Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1659-1670. PubMed ID: 29141446
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of cardiac hypertrophy by G-CSF is associated with enhanced migration of bone marrow-derived cells.
Huber BC; Beetz NL; Laskowski A; Ziegler T; Grabmaier U; Kupatt C; Herbach N; Wanke R; Franz WM; Massberg S; Brunner S
J Cell Mol Med; 2015 May; 19(5):1033-41. PubMed ID: 25754690
[TBL] [Abstract][Full Text] [Related]
12. Exosomes derived from adipose tissue, bone marrow, and umbilical cord blood for cardioprotection after myocardial infarction.
Xu H; Wang Z; Liu L; Zhang B; Li B
J Cell Biochem; 2020 Mar; 121(3):2089-2102. PubMed ID: 31736169
[TBL] [Abstract][Full Text] [Related]
13. NF-kappaB activation is required for adaptive cardiac hypertrophy.
Zelarayan L; Renger A; Noack C; Zafiriou MP; Gehrke C; van der Nagel R; Dietz R; de Windt L; Bergmann MW
Cardiovasc Res; 2009 Dec; 84(3):416-24. PubMed ID: 19620128
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitin-specific protease 19 blunts pathological cardiac hypertrophy via inhibition of the TAK1-dependent pathway.
Miao R; Lu Y; He X; Liu X; Chen Z; Wang J
J Cell Mol Med; 2020 Sep; 24(18):10946-10957. PubMed ID: 32798288
[TBL] [Abstract][Full Text] [Related]
15. Endothelial S1pr1 regulates pressure overload-induced cardiac remodelling through AKT-eNOS pathway.
Liu X; Wu J; Zhu C; Liu J; Chen X; Zhuang T; Kuang Y; Wang Y; Hu H; Yu P; Fan H; Zhang Y; Liu Z; Zhang L
J Cell Mol Med; 2020 Jan; 24(2):2013-2026. PubMed ID: 31854513
[TBL] [Abstract][Full Text] [Related]
16. Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload.
Beetz N; Rommel C; Schnick T; Neumann E; Lother A; Monroy-Ordonez EB; Zeeb M; Preissl S; Gilsbach R; Melchior-Becker A; Rylski B; Stoll M; Schaefer L; Beyersdorf F; Stiller B; Hein L
J Mol Cell Cardiol; 2016 Dec; 101():145-155. PubMed ID: 27789290
[TBL] [Abstract][Full Text] [Related]
17. LncRNA-NEAT1 from the competing endogenous RNA network promotes cardioprotective efficacy of mesenchymal stem cell-derived exosomes induced by macrophage migration inhibitory factor via the miR-142-3p/FOXO1 signaling pathway.
Chen H; Xia W; Hou M
Stem Cell Res Ther; 2020 Jan; 11(1):31. PubMed ID: 31964409
[TBL] [Abstract][Full Text] [Related]
18. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cell-derived exosomes ameliorate cardiomyocyte apoptosis in hypoxic conditions through microRNA144 by targeting the PTEN/AKT pathway.
Wen Z; Mai Z; Zhu X; Wu T; Chen Y; Geng D; Wang J
Stem Cell Res Ther; 2020 Jan; 11(1):36. PubMed ID: 31973741
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic cardiac-targeted delivery of miR-1 reverses pressure overload-induced cardiac hypertrophy and attenuates pathological remodeling.
Karakikes I; Chaanine AH; Kang S; Mukete BN; Jeong D; Zhang S; Hajjar RJ; Lebeche D
J Am Heart Assoc; 2013 Apr; 2(2):e000078. PubMed ID: 23612897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
